Results for First-Line Pembrolizumab in Advanced Urothelial Carcinoma

For patients who underwent radical cystectomy for bladder cancer, those with lower net worth incurred higher costs posttreatment.

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.

A new study found that Black patients with prostate cancer were less likely to get new treatments and had a higher risk of death than White patients.

In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, delves into the critical topic of prostate cancer screening and discusses some of the recent advancements in the prostate cancer space.

Aaron Lisberg, MD, discussed the phase 3 TROPION-Lung01 study which evaluated datopotamab deruxtecan for patients with advanced or metastatic non-small cell lung cancer.

Sarah Lee, MD, MBA, discussed a study to better disaggregate the subgroup of Asian American patients with ovarian cancer.